Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Hypersensitivity to Amylin in Post-Traumatic Headache: A Randomized Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07340775
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:38.446009+00:00
Published At
2026-01-14T00:00:00+00:00
Record Updated At
2026-01-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Headache Disorders, Secondary", "Brain Diseases", "Headache Disorders", "Nervous System Diseases", "Central Nervous System Diseases", "Neurologic Manifestations", "Signs and Symptoms", "Pathological Conditions, Signs and Symptoms", "Post-Traumatic Headache", "Pain", "Peptide Hormones", "Hormones", "Hormones, Hormone Substitutes, and Hormone Antagonists", "Peptides", "Amino Acids, Peptides, and Proteins", "Amylin", "Pramlintide"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-14"
protocolSection.identificationModule.nctId
"NCT07340775"
protocolSection.identificationModule.officialTitle
"Hypersensitivity to Amylin in Post-Traumatic Headache: A Randomized Clinical Trial"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Headache Disorders, Secondary (protocolSection.conditionsModule.conditions)
  • Brain Diseases (protocolSection.conditionsModule.conditions)
  • Headache Disorders (protocolSection.conditionsModule.conditions)
  • Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Central Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Neurologic Manifestations (protocolSection.conditionsModule.conditions)
  • Signs and Symptoms (protocolSection.conditionsModule.conditions)
  • Pathological Conditions, Signs and Symptoms (protocolSection.conditionsModule.conditions)
  • Post-Traumatic Headache (protocolSection.conditionsModule.conditions)
  • Pain (protocolSection.conditionsModule.conditions)
  • Peptide Hormones (protocolSection.conditionsModule.conditions)
  • Hormones (protocolSection.conditionsModule.conditions)
  • Hormones, Hormone Substitutes, and Hormone Antagonists (protocolSection.conditionsModule.conditions)
  • Peptides (protocolSection.conditionsModule.conditions)
  • Amino Acids, Peptides, and Proteins (protocolSection.conditionsModule.conditions)
  • Amylin (protocolSection.conditionsModule.conditions)
  • Pramlintide (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.